+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07648329

Evaluating Circulating BDNF Levels and Atrial Cardiomyopathy in Patients Undergoing Ablation for Persistent Atrial Fibrillation

Led by Centre Hospitalier Universitaire Dijon · Updated on 2026-10-26

150

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Atrial fibrillation AF is a common heart rhythm disorder linked to serious risks like strokes and heart failure. This research focuses on atrial cardiomyopathy ACM, a broader heart condition that contributes to AF. The study aims to better understand ACM by examining patients with persistent AF undergoing ablation, a treatment to correct heart rhythm, and investigating the relationship between brain-derived neurotrophic factor BDNF levels and heart tissue changes. Participants are patients scheduled for their first ablation procedure for persistent AF at a university hospital. The study observes blood samples to measure BDNF levels and uses cardiac computed tomography CT scans alongside electroanatomical mapping during ablation to assess heart tissue changes. These assessments occur before and during the ablation procedure, with follow-up measures planned one year later to track changes in BDNF and heart structure. Throughout the study, participants undergo blood draws to assess BDNF, CT scans to evaluate heart changes, and heart rhythm monitoring with Holter devices. Researchers will monitor the recurrence of AF from 3 to 12 months after ablation, correlating it with BDNF levels and heart remodeling. Clinical outcomes and rhythm changes will be observed over time, with the total study duration extending from the start date through to final assessments in 2029.

CONDITIONS

Brief Title

Association Between Circulating BDNF Levels and Atrial Cardiomyopathy in Patients Undergoing Ablation for Persistent Atrial Fibrillation

Research Team

C

Charles GUENANCIA

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here